Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Obeticholic acid or its saltsPDL I MAY / 17
ObiltoxaximabPDL I SEP / 20
ObinutuzumabPDL I DEC / 14
Oclacitinib or its saltsPDL

including but not limited to Oclacitinib maleate

I AUG / 14
OcrelizumabPDL I SEP / 17
OcriplasminPDL I DEC / 13
Octatropine methylbromidePDL I DEC / 13
OctreotidePDL I DEC / 13
OfatumumabPDL I DEC / 13
Ofloxacin or its saltsPDL

Including but not limited to levofloxacin.

I DEC / 13
Olanzapine or its saltsPDL I DEC / 13
OlaparibPDL I AUG / 16
OlaratumabPDL I MAR / 18
Oleandomycin or its salts or derivativesPDL

For human use.

I DEC / 13
Olmesartan or its salts or derivativesPDL

Including but not limited to olmesartan medoxmil.

I DEC / 13
Olodaterol or its saltsPDL I DEC / 13
Olopatadine or its saltsPDL I DEC / 13
Olsalazine or its saltsPDL I DEC / 13
OmalizumabPDL I DEC / 13
OmbitasvirPDL I MAR / 15
Omeprazole or its salts

For human use - including but not limited to omeprazole, omeprazole magnesium except when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole.

I SEP / 14
Omeprazole or its saltsPDL

For veterinary use - including but not limited to omeprazole, omeprazole magnesium.

I DEC / 13
Omeprazole or its salts.

when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole

II SEP / 14
Onasemnogene abeparvovecPDL I MAY / 21
Ondansetron or its saltsPDL I DEC / 13
Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and saltsN

Including: (1) Opium; (2) Codeine; (3) Morphine; (4) Thebaine; and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including: Acetorphine; Acetyldihydrocodeine; Benzylmorphine; Codoxime; Desomorphine; Diacetylmorphine (heroin); Dihydrocodeine; Dihydromorphine; Ethylmorphine; Etorphine; Hydrocodone; Hydromorphinol; Hydromorphone; Methyldesorphine; Methyldihydromorphine; Metopon; Morphine-N-oxide; Myrophine; Nalorphine; Nicocodine; Nicomorphine; Norcodeine; Normorphine; Oxycodone; Oxymorphone; Pholcodine; Thebacon; but not including: Apomorphine; Cyprenorphine and its salts; Nalmefene and its salts; Naloxone and its salts; Naltrexone and its salts; Methylnaltrexone and its salts; Naloxegol and its salts; Narcotine and its salts; Papaverine and its salts; Poppy seed
 

I JUN / 02
Orbifloxacin or its salts or derivativesPDL I DEC / 13
Orciprenaline (Metaproterenol) or its saltsPDL I DEC / 13
OrlistatPDL I DEC / 13
Ormetoprim or its saltsPDL I DEC / 13
OrnidazolePDL I DEC / 13
Orphenadrine citrate III SEP / 98
Orphenadrine hydrochloride I SEP / 98
Oseltamivir or its saltsPDL I DEC / 13
Osimertinib or its saltsPDL I AUG / 16
OspemifenePDL I SEP / 21
Oxacillin, or its salts or derivativesPDL

For veterinary use

I DEC / 13
OxaliplatinPDL I DEC / 13
OxanamidePDL I DEC / 13
Oxaprozin or its salts or derivativesPDL I DEC / 13
OxcarbazepinePDL I DEC / 13
Oxethazine III SEP / 98
Oxiconazole 1% for topical use U SEP / 99
Oxolinic acid or its saltsPDL I DEC / 13
Oxprenolol or its saltsPDL I DEC / 13
Oxybuprocaine and its salts

for topical use on mucous membranes, except lozenges

III SEP / 98
Oxybuprocaine and its salts

benoxinate for ophthalmic or parenteral use

II SEP / 98
Oxybutynin or its saltsPDL I DEC / 13
Oxymetazoline in nasal preparations for adult use and in ophthalmic products U
Oxymetazoline and its salts in nasal preparations for pediatric use II SEP / 98
Oxyphenbutazone or its saltsPDL I DEC / 13
Oxyquinoline II SEP / 98
Oxytetracycline or its saltsPDL

For veterinary use
 

I DEC / 18
OxytocinPDL I DEC / 13
Ozanimod or its saltsPDL I DEC / 20
Ozenoxacin or its saltsPDL I JUN / 17

56 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act